Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The proposed study represents a crucial and important stage in translating basic research to
strategies for treating nicotine dependence. The investigation addresses an important public
health issue by testing an intervention - informed by basic research - that may lead to a
more effective and efficient treatment for smokers. The expected findings should provide
initial effect size data for the addition of isradipine to an integrated
psychosocial/behavioral and pharmacological smoking cessation intervention for smokers, and
thus provide the necessary data for a large-scale follow-up trial.